CareDx Inc (CDNA)

Add to Watchlists
Create an Alert
Quickflows
64.22 +1.20  +1.90% NASDAQ May 13, 16:59 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All CDNA News

News

View All Events

Events

Date Type Description
08/04/2021 00:00 Earnings Results Q2 2021 Earnings Results
08/04/2021 16:30 Earnings Calls Q2 2021 Earnings Call
05/05/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/05/2021 16:30 EDT Earnings Calls Q1 2021 Earnings Call
02/24/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/24/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/29/2020 16:30 EDT Earnings Calls Q3 2020 Earnings Call
08/04/2020 16:30 EDT Earnings Calls Q2 2020 Earnings Call
08/04/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 221.21M
Total Expenses (TTM) 238.85M
Net Income (TTM) -13.58M

Balance Sheet View Statement

Total Assets (Quarterly) 541.22M
Total Liabilities (Quarterly) 69.68M
Shareholders Equity (Quarterly) 471.55M

Cash Flow Statement View Statement

Cash from Operations (TTM) 2.856M
Cash from Investing (TTM) -79.61M
Cash from Financing (TTM) 353.11M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey, and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.
  • URL: https://www.caredx.com
  • Investor Relations URL: https://investors.caredxinc.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 04, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 64.22
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 3.92%
AOFCX Alger Small Cap Focus C 3.80%
ARKG ARK Genomic Revolution ETF 3.72%
EAGB.NO Emerge ARK Genomics & Biotech ETF 3.67%
PBE Invesco Dynamic Biotech & Genome ETF 2.52%
WSGBX Ivy Small Cap Growth B 2.50%
BDFUX Baron Discovery R6 2.08%
FVUSA04AWV JNL/Invesco Small Cap Growth I 1.57%
LMPMX ClearBridge Small Cap Growth 1 1.52%
GTSDX Invesco Small Cap Growth C 1.49%
HTEC Robo Global® Hlthcare Tech & Innovt ETF 1.43%
MIND.TO Horizons Active A.I. Global Equity ETF 1.24%

Comparables

Edit
TNDM Tandem Diabetes Care Inc
MMSI Merit Medical Systems Inc
STAA Staar Surgical Co
NVRO Nevro Corp
VAPO Vapotherm Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.